Quotient Sciences Limited Sustainability Profile
Quotient Sciences Limited, a leading provider of integrated drug development and manufacturing solutions, is headquartered in Great Britain. Founded in 2016, the company has rapidly established itself within the pharmaceutical and biotechnology sectors, offering a comprehensive range of services that span from early-phase development to commercial manufacturing. With operational facilities across the UK and the US, Quotient Sciences excels in delivering innovative solutions such as formulation development, clinical trial supply, and analytical services. Their unique approach combines expertise in both drug development and manufacturing, ensuring streamlined processes that enhance efficiency and reduce time to market. Recognised for its commitment to quality and customer-centric solutions, Quotient Sciences has achieved significant milestones, positioning itself as a trusted partner for companies looking to advance their drug development programmes.
DitchCarbon Score
How does Quotient Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quotient Sciences Limited's score of 30 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Quotient Sciences Limited's reported carbon emissions
In 2024, Quotient Sciences Limited reported total carbon emissions of approximately 20.4 million kg CO2e. This total comprises Scope 1 emissions of about 2.4 million kg CO2e, Scope 2 emissions of approximately 3.9 million kg CO2e, and Scope 3 emissions amounting to around 14.1 million kg CO2e. Quotient Sciences is committed to reducing its carbon footprint, although specific reduction targets have not been disclosed. The company is classified as "Committed" to near-term targets under the Science Based Targets initiative (SBTi), indicating a proactive approach to climate action within the pharmaceuticals, biotechnology, and life sciences sector. As a UK-based organisation, Quotient Sciences is part of a growing movement within its industry to address climate change and enhance sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 2,368,000 |
| Scope 2 | 3,865,000 |
| Scope 3 | 14,123,000 |
How Carbon Intensive is Quotient Sciences Limited's Industry?
How Carbon Intensive is Quotient Sciences Limited's Location?
Quotient Sciences Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Quotient Sciences Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Quotient Sciences Limited's sustainability data and climate commitments
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.